Aureus Asset Management LLC increased its position in CME Group Inc. (NASDAQ:CME – Get Rating) by 4.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,778 shares of the financial services provider’s stock after purchasing an additional 716 shares during the quarter. Aureus Asset Management LLC’s holdings in CME Group were worth $3,158,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. RB Capital Management LLC boosted its position in CME Group by 11.4% during the 1st quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock valued at $338,000 after acquiring an additional 145 shares in the last quarter. Prudential PLC purchased a new position in shares of CME Group during the 1st quarter valued at about $1,709,000. Cetera Investment Advisers raised its stake in shares of CME Group by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock valued at $829,000 after buying an additional 190 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new position in shares of CME Group during the 1st quarter valued at about $281,000. Finally, Candriam Luxembourg S.C.A. raised its stake in shares of CME Group by 9.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock valued at $6,001,000 after buying an additional 2,181 shares during the last quarter. Institutional investors own 85.09% of the company’s stock.
Wall Street Analysts Forecast Growth
CME has been the topic of a number of analyst reports. JPMorgan Chase & Co. dropped their target price on CME Group from $196.00 to $194.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 19th. StockNews.com started coverage on CME Group in a research report on Thursday, May 18th. They set a “hold” rating on the stock. Oppenheimer lifted their price objective on CME Group from $213.00 to $221.00 and gave the stock an “outperform” rating in a report on Wednesday, April 12th. Rosenblatt Securities reiterated a “sell” rating and issued a $161.00 price objective on shares of CME Group in a report on Wednesday, April 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $206.00 to $208.00 in a report on Thursday, April 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $210.50.
CME Group Trading Down 0.9 %
CME Group (NASDAQ:CME – Get Rating) last issued its earnings results on Wednesday, April 26th. The financial services provider reported $2.42 earnings per share for the quarter, topping the consensus estimate of $2.36 by $0.06. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. CME Group had a return on equity of 10.88% and a net margin of 55.99%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 EPS. Analysts predict that CME Group Inc. will post 8.73 EPS for the current fiscal year.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Friday, June 9th will be given a dividend of $1.10 per share. This represents a $4.40 annualized dividend and a dividend yield of 2.48%. The ex-dividend date is Thursday, June 8th. CME Group’s payout ratio is presently 55.91%.
About CME Group
CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.
Featured Articles
- Get a free copy of the StockNews.com research report on CME Group (CME)
- As Peloton Shares Fall Over 90%, A Comeback Strategy Surges
- Inflation, The Fed, And The Summer Rally
- How to Trade Stocks Online the Right Way
- SentinelOne Stock is Down, But Is it Out?
- Oracle Has Spoken: The AI Cloud Is Bigger And Growing Faster
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
